Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.
CONCLUSIONS: Our results suggest that targeted therapies are safe in patients with SAPH. Controlled trials are warranted before therapeutic recommendations can be made.
PMID: 25078636 [PubMed - in process]
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - Category: Respiratory Medicine Tags: Sarcoidosis Vasc Diffuse Lung Dis Source Type: research
More News: Brain | Cardiology | Heart | Heart Transplant | Hypertension | Lung Transplant | Neurology | Pulmonary Artery Catheterization | Pulmonary Function Testing | Pulmonary Hypertension | Respiratory Medicine | Sarcoidosis | Transplants | Vasculitis | Viagra | WHO